5 news items
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
VIR
23 May 24
at the close of business on April 1, 2024, the record date for the Annual Meeting, can attend and vote at the Annual Meeting by accessing the meeting
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
VIR
13 May 24
Organization. (AprilĀ 2024). Global hepatitis report 2024: action for access in low- and middle-income
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
VIR
11 Apr 24
.
The corporate update and financial results will be provided via a press release after market close and will be accessible under Press Releases
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
ANTX
VBIV
VIR
22 Mar 24
will receive an email with important details for this call, including the call date, time and access link. This link is to be kept confidential
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
VIR
5 Mar 24
; challenges in accessing manufacturing capacity; clinical site activation rates or clinical trial enrollment rates that are lower than expected; difficulties
- Prev
- 1
- Next